Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05981573 · ClinicalTrials.gov registry record
Assessment of Methadone Dose Taken
A clinical trial of Pain, Chronic and Drug Metabolism, Poor, CYP2D6-Related, sponsored by Cari Health.
- Recruiting
- Registry status
- 30
- Enrollment target
- 1
- Study location
NCT05981573 is a study of Pain, Chronic and Drug Metabolism, Poor, CYP2D6-Related that is actively recruiting participants, run by Cari Health. The registered enrollment target is 30 participants, below the 721-participant average among 48 other Pain, Chronic trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05981573, a study of Pain, Chronic and Drug Metabolism, Poor, CYP2D6-Related, is actively recruiting participants, sponsored by Cari Health.
- RECRUITING
- Registry status
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
Proof of concept: Pilot Study A Pilot, proof of concept, observational study with a long-term goal to develop a minimally invasive wearable Remote Medication Monitor (RMM) that provides continuous, real-time data on methadone levels in interstitial fluid (ISF). An RMM could be used as a medication adherence monitor and would allow for the physician, counselor, patient, or family member to remotely verify that a physician-prescribed dose has been taken.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Measurement of Methadone in the Interstitial Fluid (ISF) before and after prescribed dose taken ex vivo
- DRUG Measurement of Methadone in the Interstitial Fluid before and after prescribed dose taken in vivo
- DEVICE ISF Extraction Device 2
Study Locations (1)
California
- Synergy - Lemon Grove
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2024-08-26 |
| Est. Completion | 2026-04 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05981573
The ClinicalTrials.gov registry entry for NCT05981573 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 721-participant average among 48 other Pain, Chronic trials with a reported enrollment target (96% lower). The listed sponsor is Cari Health, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 5 conditions, with Pain, Chronic appearing as the primary indexed condition, and to 3 interventions - of which Measurement of Methadone in the Interstitial Fluid (ISF) before and after prescribed dose taken ex vivo is the first listed.
NCT05981573 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT05981573 about?
NCT05981573 is a clinical study titled "Assessment of Methadone Dose Taken". Proof of concept: Pilot Study A Pilot, proof of concept, observational study with a long-term goal to develop a minimally invasive wearable Remote Medication Monitor (RMM) that provides continuous, real-time data on methadone levels in interstitial fluid (ISF). An RMM could be used as a medication ...
What is the current status of trial NCT05981573?
This trial is currently recruiting. The enrollment target is 30 participants. The study started on 2024-08-26. Estimated completion is 2026-04.
What conditions does trial NCT05981573 study?
This clinical trial studies the following conditions: Pain, Chronic, Drug Metabolism, Poor, CYP2D6-Related, Methadone Toxicity, Methadone Overdose, Metabolism Medication Toxicity.
What interventions are being tested in trial NCT05981573?
The interventions under investigation include: Measurement of Methadone in the Interstitial Fluid (ISF) before and after prescribed dose taken ex vivo (DIAGNOSTIC_TEST), Measurement of Methadone in the Interstitial Fluid before and after prescribed dose taken in vivo (DRUG), ISF Extraction Device 2 (DEVICE).
Who is sponsoring clinical trial NCT05981573?
This trial is sponsored by Cari Health, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05981573 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pain, Chronic
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Comparative Effectiveness of Online 8-session CBT vs. 1-Session Empowered Relief for Chronic Pain - The PROGRESS Study
RECRUITING · NA
-
Pain and Weight Treatment: Development and Trial of PAW
RECRUITING · NA
-
VR and Cooled Genicular Nerve Radio Frequency Ablation for Chronic Knee Pain
RECRUITING · NA
-
The PROACTIVE Study for Black Elders
RECRUITING · NA
-
Screening Trial for Pain Relief in Schwannomatosis (STARFISH)
RECRUITING · Phase 2
-
Pain Reprocessing Therapy in Post-Operative Knee Pain
RECRUITING · Phase 2
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.